Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study.

Hidese, Shinsuke; Yoshida, Fuyuko; Ishida, Ikki; Matsuo, Junko; Hattori, Kotaro; Kunugi, Hiroshi

Hidese, Shinsuke; Yoshida, Fuyuko; Ishida, Ikki; Matsuo, Junko; Hattori, Kotaro; Kunugi, Hiroshi.

Afiliação

Hidese S; Department of Psychiatry, Teikyo University School of Medicine, Itabashi-ku, Japan.
Yoshida F; Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.
Ishida I; Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
Matsuo J; Department of Psychiatry, Teikyo University School of Medicine, Itabashi-ku, Japan.
Hattori K; Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.
Kunugi H; Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Neuropsychopharmacol Rep ; 43(1): 57-68, 2023 03.

Article em En | MEDLINE | ID: mdl-36414415

Assuntos

Transtorno Bipolar; Transtorno Depressivo Maior; Esquizofrenia; Humanos; Transtorno Bipolar/complicações; beta-Endorfina; Neurotensina; Substância P; Ocitocina; alfa-MSH; Imunoensaio

Palavras-chave

cognitive function; major psychiatric disorders; neuropeptide; symptom

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtorno Bipolar / Transtorno Depressivo Maior Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google